Abstract:Introduction: The risk of alcoholic cirrhosis increases in a dose- and time-dependent manner with alcohol consumption and ethanol metabolism in the liver. Currently, no effective antifibrotic therapies are available. We aimed to obtain a better understanding of the cellular and molecular mechanisms involved in the pathogenesis of liver cirrhosis. Methods: We performed single-cell RNA-sequencing to analyze immune cells from the liver tissue and peripheral blood form patients with alcoholic cirrhosis and healthy controls to profile the transcriptomes of more than 100,000 single human cells and yield molecular definitions for non-parenchymal cell types. In addition, we performed single-cell RNA-sequencing analysis to reveal the immune microenvironment related to alcoholic liver cirrhosis. Hematoxylin and eosin, Immunofluorescence staining and Flow cytometric analysis were employed to study the difference between tissues and cells with or without alcoholic cirrhosis. Results: We identified a fibrosis-associated M1 subpopulation of macrophages that expands in liver fibrosis, differentiates from circulating monocytes, and is pro-fibrogenic. We also define mucosal-associated invariant T (MAIT) cells that expand in alcoholic cirrhosis and are topographically restricted to the fibrotic niche. Multilineage modeling of ligand and receptor interactions between the fibrosis-associated macrophages, MAIT, and NK cells revealed the intra-fibrotic activity of several pro-fibrogenic pathways, including responses to cytokines and antigen processing and presentation, natural killer cell-mediated cytotoxicity, cell adhesion molecules, Th1/Th2/Th17 cell differentiation, IL-17 signaling pathway, and Toll-like receptor signaling pathway. Discussion: Our work dissects unanticipated aspects of the cellular and molecular basis of human organ alcoholic fibrosis at the single-cell level and provides a conceptual framework for the discovery of rational therapeutic targets in liver alcoholic cirrhosis.

Key regulators of hepatic stellate cell activation in alcohol liver Disease: A comprehensive review

Regulatory Long Non-Coding RNAs of Hepatic Stellate Cells in Liver Fibrosis (Review)

Hepatic stellate cells and innate immunity in alcoholic liver disease

Alcoholic Hepatitis: A Review

Liver regeneration and alcoholic liver disease

Alcohol and the mechanisms of liver disease

A review on molecular mechanism of alcoholic liver disease

Pathogenic mechanisms and regulatory factors involved in alcoholic liver disease

Recent Advances in Understanding of Pathogenesis of Alcohol-Associated Liver Disease

Alcohol-associated liver disease: A review on its pathophysiology, diagnosis and drug therapy

New insights into the bile acid-based regulatory mechanisms and therapeutic perspectives in alcohol-related liver disease

Alcohol-Associated Liver Disease Outcomes: Critical Mechanisms of Liver Injury Progression

Targeting Inflammation for the Treatment of Alcoholic Liver Disease.

Cell-to-Cell Communications in Alcohol-Associated Liver Disease.

Critical Roles of Kupffer Cells in the Pathogenesis of Alcoholic Liver Disease: from Basic Science to Clinical Trials

Advancements in the Alcohol-Associated Liver Disease Model

Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets

The role of PI3k/AKT signaling pathway in attenuating liver fibrosis: a comprehensive review

Dysregulation of innate cell types in the hepatic immune microenvironment of alcoholic liver cirrhosis

Inhibition of Autophagy Reverses Alcohol-Induced Hepatic Stellate Cells Activation Through Activation of Nrf2-Keap1-ARE Signaling Pathway

Molecular insights on intracellular Wnt/β‐catenin signaling in alcoholic liver disease